Article Text

Download PDFPDF
Basic science for the chest physician
IL-17 in lung disease: friend or foe?
  1. Hui-Leng Tan1,2,
  2. Mark Rosenthal2
  1. 1Leukocyte Biology, National Heart and Lung Institute, Imperial College, London, UK
  2. 2Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK
  1. Correspondence to Dr Hui-Leng Tan, Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, SW3 6NP, UK; h.tan{at}


Interleukin 17 (IL-17) is a key proinflammatory cytokine in the T helper 17 pathway. While it is important in the clearance of certain pathogens, IL-17 has been shown to contribute to the pathogenesis of such inflammatory diseases as rheumatoid arthritis and psoriasis. In the lung, it has been postulated to be involved in the neutrophilic inflammation and airway remodelling of chronic respiratory conditions but the situation is increasingly complex. This review summarises the evidence for its role in several chronic inflammatory lung diseases: asthma, obliterative bronchiolitis, chronic obstructive pulmonary disease, sarcoidosis and cystic fibrosis.

  • Cytokine Biology
  • Asthma
  • Cystic Fibrosis
  • Respiratory Infection

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles